The research findings primarily focus on individuals with a sleep disorder but may have broader implications. A recent study ...

For people with a certain sleep disorder, a simple blood test could help predict the development of dementia years before ...

A new batch of neflamapimod capsules led to increased plasma drug concentrations and demonstrated improvement (p<0.001 vs. old capsules; p=0.003 vs. placebo) on the primary outcome measure, change ...

For people with a certain sleep disorder, a simple blood test could help predict the development of dementia years before symptoms appear, a new study indicates. Idiopathic REM sleep behavior disorder ...

Idiopathic REM sleep behaviour disorder is associated with a very high risk of Parkinson's disease and a related condition called Dementia with Lewy Bodies.

CervoMed's Phase 2b study extension shows improved cognitive outcomes with neflamapimod, leading to an analyst upgrade and ...

CervoMed has announced positive results from the extension phase 2b RewinD-LB study of neflamapimod for dementia with Lewy ...

Researchers at McGill University found that a blood test originally designed for Alzheimer’s can predict dementia risk in ...

JonesResearch upgraded CervoMed (CRVO) to Buy from Hold with a $15 price target arguing that the company’s latest data from the open label ...

The disorder is also associated with a very high risk of Parkinson's disease and a related condition called Dementia with Lewy Bodies. This is a form of dementia that often causes memory and ...

CervoMed (Nasdaq: CRVO) has announced encouraging findings from the first 16 weeks of the extension phase of its Phase IIb ...